Vimarsana
Biggest News Aggregation in the World

Page 32 - Science User Facility News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Science User Facility. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Science User Facility Today - Breaking & Trending Today

10 ways Argonne science is combatting COVID-19 | US Department of Energy Science News - Vimarsana News

10 ways Argonne science is combatting COVID-19 | US Department of Energy Science News

DOE/Argonne National Laboratory Argonne scientists and research facilities have made a difference in the fight against COVID-19 in the year since the first gene sequence for the virus was published. Sunday, Jan. 10, will mark one year since the first gene sequence for the virus that causes COVID-19 was published, igniting the quest for vaccines and treatments. Ten days later, the first case of the virus was confirmed in the United States. The U.S. Department of Energy's (DOE) Argonne National Laboratory pivoted immediately to join the global fight against the pandemic, turning our powe...

Argonne earns HPCwire awards for supercomputing excellence in energy and industry - Vimarsana News

Argonne earns HPCwire awards for supercomputing excellence in energy and industry

 E-Mail IMAGE: The Argonne team of Sibendu Som, Muhsin Ameen and Saumil Patel won the Readers' Choice Award for Best Use of HPC in Energy. view more  Credit: (Image by HPCwire.) HPCwire magazine recognizes two Argonne teams for outstanding achievement in their use of high performance computing. Two teams of scientists from the U.S. Department of Energy's (DOE) Argonne National Laboratory have won HPCwire Awards, recognizing their innovative use of high performance computing (HPC) to optimize engine design. The awards were presented by HPCwire magazine. The Readers' Choice Award for ...

Research at Advanced Photon Source laid the groundwork for effective COVID-19 vaccines - Vimarsana News

Research at Advanced Photon Source laid the groundwork for effective COVID-19 vaccines

Research at Advanced Photon Source laid the groundwork for effective COVID-19 vaccines There is light at the end of the COVID-19 pandemic tunnel. Several vaccines against the SARS-CoV-2 virus that causes COVID-19 are now in clinical trials, with one -- developed by Pfizer/BioNTech -- already having been approved for emergency use in the United States. This has been the fastest development and rollout of any vaccine in history, starting with the first gene sequence released in January. (The previous record was held by the mumps vaccine, which took four years.) But while this may seem like an o...

Argonne plays foundational role in development of COVID-19 vaccines - Press Release - Vimarsana News

Argonne plays foundational role in development of COVID-19 vaccines - Press Release

Argonne plays foundational role in development of COVID-19 vaccines LEMONT, Ill.--(Business Wire)--As the COVID-19 vaccines roll out across the country, the record-setting pace of the vaccine development may seem to many like an overnight success story. In reality, it was built on more than a decade of research into other viruses at the U.S Department of Energy's (DOE) Argonne National Laboratory’s Advanced Photon Source (APS). Advanced Photon Source at Argonne National Laboratory (Photo: Business Wire) Five of the vaccines, including those developed by Pfizer/BioNTech and Moderna, contai...

APS plays foundational role in development of COVID-19 vaccines - Vimarsana News

APS plays foundational role in development of COVID-19 vaccines

 E-Mail IMAGE: Data taken at the APS shows the neutralizing antibody D25 binding to the F protein of the Respiratory Syncytial Virus (RSV). This binding stabilizes the protein in its prefusion form.... view more  Credit: Jason McLellan There is light at the end of the COVID-19 pandemic tunnel. Several vaccines against the SARS-CoV-2 virus that causes COVID-19 are now in clinical trials, with one -- developed by Pfizer/BioNTech -- already having been approved for emergency use in the United States. This has been the fastest development and rollout of any vaccine in history, starting ...